148 related articles for article (PubMed ID: 28379361)
21. Specific Antibody Deficiencies in Clinical Practice.
Sorensen RU; Edgar D
J Allergy Clin Immunol Pract; 2019 Mar; 7(3):801-808. PubMed ID: 30682575
[TBL] [Abstract][Full Text] [Related]
22. A Critical View of Specific Antibody Deficiencies.
Sorensen RU
Front Immunol; 2019; 10():986. PubMed ID: 31118939
[No Abstract] [Full Text] [Related]
23. Mucosal and systemic immunization with pneumococcal polysaccharide type 3, 4 and 14 in the rat.
van den Dobbelsteen GP; Brunekreef K; Sminia T; van Rees EP
Adv Exp Med Biol; 1995; 371B():1605-10. PubMed ID: 7502866
[No Abstract] [Full Text] [Related]
24. Pneumococcal polysaccharide immunization in infants and children.
Cowan MJ; Ammann AJ; Wara DW; Howie VM; Schultz L; Doyle N; Kaplan M
Pediatrics; 1978 Nov; 62(5):721-7. PubMed ID: 31592
[TBL] [Abstract][Full Text] [Related]
25. Capsular Polysaccharide (CPS) Release by Serotype 3 Pneumococcal Strains Reduces the Protective Effect of Anti-Type 3 CPS Antibodies.
Choi EH; Zhang F; Lu YJ; Malley R
Clin Vaccine Immunol; 2016 Feb; 23(2):162-7. PubMed ID: 26677201
[TBL] [Abstract][Full Text] [Related]
26. Value of allohaemagglutinins in the diagnosis of a polysaccharide antibody deficiency.
Schaballie H; Vermeulen F; Verbinnen B; Frans G; Vermeulen E; Proesmans M; De Vreese K; Emonds MP; De Boeck K; Moens L; Picard C; Bossuyt X; Meyts I
Clin Exp Immunol; 2015 May; 180(2):271-9. PubMed ID: 25516411
[TBL] [Abstract][Full Text] [Related]
27. Defective antipneumococcal polysaccharide antibody response in children with recurrent respiratory tract infections.
Sanders LA; Rijkers GT; Kuis W; Tenbergen-Meekes AJ; de Graeff-Meeder BR; Hiemstra I; Zegers BJ
J Allergy Clin Immunol; 1993 Jan; 91(1 Pt 1):110-9. PubMed ID: 8423268
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of the immune response to pneumococcal capsular polysaccharides.
Jeurissen A; Boudewijns M; Proesmans M; Ceuppens JL; De Boeck K; Bossuyt X
Acta Clin Belg; 2003; 58(2):106-10. PubMed ID: 12836493
[TBL] [Abstract][Full Text] [Related]
29. Optimal assessment of the ability of children with recurrent respiratory tract infections to produce anti-polysaccharide antibodies.
Tuerlinckx D; Vermeulen F; Pékus V; de Bilderling G; Glupczynski Y; Collet S; Jamart J; Bodart E; Mascart F
Clin Exp Immunol; 2007 Aug; 149(2):295-302. PubMed ID: 17511778
[TBL] [Abstract][Full Text] [Related]
30. Does naturally acquired IgG antibody to cell wall polysaccharide protect human subjects against pneumococcal infection?
Musher DM; Watson DA; Baughn RE
J Infect Dis; 1990 Apr; 161(4):736-40. PubMed ID: 2319167
[TBL] [Abstract][Full Text] [Related]
31. Antibodies against pneumococcal C-polysaccharide are not protective.
Nielsen SV; Sørensen UB; Henrichsen J
Microb Pathog; 1993 Apr; 14(4):299-305. PubMed ID: 8326853
[TBL] [Abstract][Full Text] [Related]
32. The acquisition of anti-pneumococcal capsular polysaccharide Haemophilus influenzae type b and tetanus toxoid antibodies, with age, in the UK.
Hazlewood M; Nusrat R; Kumararatne DS; Goodall M; Raykundalia C; Wang DG; Joyce HJ; Milford-Ward A; Forte M; Pahor A
Clin Exp Immunol; 1993 Aug; 93(2):157-64. PubMed ID: 8348740
[TBL] [Abstract][Full Text] [Related]
33. Impact of Using Different Response Criteria for Pneumococcal Polysaccharide Vaccination for Assessment of Humoral Immune Status.
Hoffman TW; van Kessel DA; Rijkers GT
J Clin Immunol; 2018 Feb; 38(2):149-152. PubMed ID: 29247371
[No Abstract] [Full Text] [Related]
34. Antipolysaccharide antibodies in 450 children with otitis media.
Misbah SA; Griffiths H; Mitchell T; Freeland A; Haeney MR; Chapel HM
Clin Exp Immunol; 1997 Jul; 109(1):67-72. PubMed ID: 9218826
[TBL] [Abstract][Full Text] [Related]
35. Modulatory role of intravenous gammaglobulin (IgIV) on the in vitro antibody response to a pneumococcal polysaccharide antigen.
Leiva LE; Monjure H; Sorensen RU
J Clin Immunol; 2015 Feb; 35(2):206-12. PubMed ID: 25504423
[TBL] [Abstract][Full Text] [Related]
36. Long-term protection after immunization with protein-polysaccharide conjugate vaccines in infancy.
Blanchard-Rohner G; Pollard AJ
Expert Rev Vaccines; 2011 May; 10(5):673-84. PubMed ID: 21604987
[TBL] [Abstract][Full Text] [Related]
37. Pneumococcal conjugate vaccine primes for polysaccharide-inducible IgG2 antibody response in children with recurrent otitis media acuta.
Breukels MA; Rijkers GT; Voorhorst-Ogink MM; Zegers BJ; Sanders LA
J Infect Dis; 1999 May; 179(5):1152-6. PubMed ID: 10191217
[TBL] [Abstract][Full Text] [Related]
38. Assessment and clinical interpretation of polysaccharide antibody responses.
Paris K; Sorensen RU
Ann Allergy Asthma Immunol; 2007 Nov; 99(5):462-4. PubMed ID: 18051217
[TBL] [Abstract][Full Text] [Related]
39. The Use of Salmonella Typhim Vaccine to Diagnose Antibody Deficiency.
Bausch-Jurken MT; Verbsky JW; Gonzaga KA; Elms NP; Hintermeyer MK; Gauld SB; Routes JM
J Clin Immunol; 2017 Jul; 37(5):427-433. PubMed ID: 28589420
[TBL] [Abstract][Full Text] [Related]
40. A Streptococcus pneumoniae Type 2 Oligosaccharide Glycoconjugate Elicits Opsonic Antibodies and Is Protective in an Animal Model of Invasive Pneumococcal Disease.
Emmadi M; Khan N; Lykke L; Reppe K; G Parameswarappa S; Lisboa MP; Wienhold SM; Witzenrath M; Pereira CL; Seeberger PH
J Am Chem Soc; 2017 Oct; 139(41):14783-14791. PubMed ID: 28945368
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
